Get started
Author

Jeremy P. Hing

Phase I Pharmacologic and Pharmacodynamic Study of the Gamma Secretase (Notch) Inhibitor MK-0752 in Adult Patients With Advanced Solid Tumors
2012 · Ian Krop, Tim Demuth, et al. · Journal of Clinical Oncology · 328
PDF
Peri-operative risk factors for acute lung injury after elective oesophagectomy
2001 · S. Tandon, A. Batchelor, et al. · British Journal of Anaesthesia · 196
Temperature-dependent Pharmacokinetics and Pharmacodynamics of Vecuronium
2000 · James E. Caldwell, Tom Heier, et al. · Anesthesiology · 130
PDF
Ceftazidime‐Avibactam Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Across Adult Indications and Patient Subgroups
2018 · Jianguo Li, Mark Lovern, et al. · Clinical and Translational Science · 103
PDF
Analysis of Toxicokinetic Data Using NONMEM: Impact of Quantification Limit and Replacement Strategies for Censored Data
2001 · Jeremy P. Hing, Steven G. Woolfrey, et al. · Journal of Pharmacokinetics and Pharmacodynamics · 52
Pharmacodynamic Analysis of Recombinant Human Erythropoietin Effect on Reticulocyte Production Rate and Age Distribution in Healthy Subjects
2008 · Juan José Pérez-Ruixo, Wojciech Krzyzanski, et al. · Clinical Pharmacokinetics · 45
Mechanism-based Pharmacokinetic/Pharmacodynamic Meta-analysis of Trabectedin (ET-743, Yondelis) Induced Neutropenia
2007 · J Hing, J J Perez-Ruixo, et al. · Clinical Pharmacology & Therapeutics · 42
Pharmacokinetics and Exposure-Response Relationships of Dasotraline in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults
2015 · Seth C. Hopkins, Soujanya Sunkaraneni, et al. · Clinical Drug Investigation · 31
PDF
Is Mixed Effects Modeling or Naïve Pooled Data Analysis Preferred for the Interpretation of Single Sample per Subject Toxicokinetic Data?
2001 · Jeremy P. Hing, Steven G. Woolfrey, et al. · Journal of Pharmacokinetics and Pharmacodynamics · 25
Pharmacokinetic simulation for switching from galantamine immediate-release to extended-release formulation
2005 · Jeremy P. Hing, Vladimir Piotrovsky, et al. · Current Medical Research and Opinion · 11
Antagonism of rapacuronium using edrophonium or neostigmine: pharmacodynamics and pharmacokinetics
1999 · K G Mills, P M Wright, et al. · British Journal of Anaesthesia · 10
PDF
Pharmacokinetic–pharmacodynamic (dipeptidyl peptidase‐4 inhibition) model to support dose rationale in diabetes patients, including those with renal impairment, for once‐weekly administered omarigliptin
2019 · Lokesh Jain, Anne S.Y. Chain, et al. · British Journal of Clinical Pharmacology · 9
Distinguishing animal subsets in toxicokinetic studies: comparison of non‐linear mixed effects modelling with non‐compartmental methods
2002 · Jeremy P. Hing, Steven G. Woolfrey, et al. · Journal of Applied Toxicology · 6
An accessible pharmacodynamic transcriptional biomarker for notch target engagement
2016 · KQ Tanis, AA Podtelezhnikov, et al. · Clinical Pharmacology & Therapeutics · 5
PDF
Abstract B41: Identification of a time- and dose-responsive transcriptional signature of Notch pathway inhibition in plucked human hair follicles following exposure to the gamma-secretase inhibitor MK-0752
2009 · Samuel C. Blackman, Joel A. Klappenbach, et al. · Molecular Cancer Therapeutics · 5
Population Pharmacokinetic and Pharmacodynamic Modeling of LY2510924 in Patients With Advanced Cancer
2017 · S Bihorel, E Raddad, et al. · CPT Pharmacometrics & Systems Pharmacology · 4
PDF
Semi-physiological pharmacokinetic/pharmacodynamic (PKPD) model for trabectedin-induced neutropenia
2006 · J. Hing, J. Perez Ruixo, et al. · Journal of Clinical Oncology
Development and Application of a Semi-Mechanistic Model for Modulation of Amyloid-β in Cerebrospinal Fluid after Inhibition of γ-secretase
2006 · Huub Jan Kleijn, Jeremy Hing, et al.
The application of non-linear mixed effects modelling to toxicokinetic data : population pharmacokinetics in preclinical studies.
2002 · Hing Jp · Europe PMC (PubMed Central)
Works count: 19
Citation count: 1,002
H-index: 10
I10-index: 11
Year
Topic
Type